Letter from the Editor

According to recent statistics published by the American Cancer Society (ACS), an estimated 102,900 new cases of colon cancer were diagnosed in 2010, resulting in an […]

Letter from the Editor

Last month, the United States Department of Agriculture (USDA) unveiled the federal government’s new food icon, MyPlate, a tool designed to help Americans make healthier food […]

Letter from the Editor

Just as this issue was being prepared for publication, the US Food and Drug Administration approved both boceprevir (Victrelis, Merck) and telaprevir (Incivek, Vertex), marking the start […]

Letter from the Editor

Last month, I discussed how medicine is always changing: how new information continues to alter our understanding of various conditions and their treatments. While ongoing developments […]

Letter from the Editor

Medicine is a continually evolving field. Occasionally, we encounter advances in knowledge that are relatively straightforward: a gene is found that explains how and why a […]

Letter from the Editor

Prior to the introduction of biologic medications, treatment of inflammatory bowel disease (IBD) often involved choosing among less-than-ideal options. For example, corticosteroids can effectively quell inflammation […]

Letter from the Editor

Large, multicenter, randomized clinical trials lay at the foundation of virtually all areas of medicine. While a case report, single-center study, or retrospective chart review certainly […]

Letter from the Editor

As we start the new year, now is a good time to reflect on how gastroenterology and hepatology have changed over the past 12 months. Although […]